Conavi Medical Income Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Dec '21 Dec 31, 2021
Revenue	0.78	9.12	2.16	25.4
Revenue Growth (YoY)	-91.44%	322.12%	-91.49%	-
Cost of Revenue	0.03	1.5	2.11	-
Gross Profit	0.74	7.63	0.05	25.4
Selling, General & Admin	7.34	6.15	7.07	16.17
Depreciation & Amortization Expenses	0.77	0.81	0.99	-
Research & Development	11.37	15.27	17.94	48.3
Other Operating Expenses	0.33	5.24	0.29	-
Total Operating Expenses	19.81	27.47	26.29	64.47
Operating Income	-19.07	-19.84	-26.23	-39.07
Interest Income	-	-	-	0.09
Interest Expense	-	-	-	-0.23
Other Non-Operating Income (Expense)	-2.86	10.84	9.3	20.51
Total Non-Operating Income (Expense)	-2.86	10.84	9.3	20.37
Pretax Income	-21.93	-9	-16.93	-18.71
Provision for Income Taxes	-	-	-	0.07
Net Income	-21.93	-9	-16.93	-18.78
Net Income to Common	-21.93	-9	-16.93	-18.78
Shares Outstanding (Basic)	81	58	58	67
Shares Outstanding (Diluted)	81	58	58	67
Shares Change (YoY)	535.67%	-	-14.18%	-
EPS (Basic)	-0.59	-0.36	-7.08	-0.18
EPS (Diluted)	-0.59	-0.36	-7.08	-0.18
Free Cash Flow	-23.74	-25.17	-20.72	0
Free Cash Flow Per Share	-0.29	-0.44	-0.36	-
Gross Margin	95.63%	83.61%	2.45%	100.00%
Operating Margin	-2451.22%	-217.49%	-1213.93%	-153.86%
Profit Margin	-2818.83%	-98.68%	-783.43%	-73.95%
FCF Margin	-3050.90%	-275.96%	-958.95%	0.00%
EBITDA	-18.37	-19.33	-25.71	-39.07
EBITDA Margin	-2361.76%	-211.93%	-1189.59%	-153.86%
EBIT	-19.07	-19.84	-26.23	-39.07
EBIT Margin	-2451.22%	-217.49%	-1213.93%	-153.86%
Effective Tax Rate	-	0.00%	0.00%	-0.38%